Urmăriți
Prof. Dr. Veerasamy Ravichandran
Prof. Dr. Veerasamy Ravichandran
Head, Unit of Pharmaceutical Chemistry, Faculty of Pharmacy, AIMST University, MALAYSIA
Adresă de e-mail confirmată pe aimst.edu.my
Titlu
Citat de
Citat de
Anul
Biosynthesis of silver nanoparticles using mangosteen leaf extract and evaluation of their antimicrobial activities
R Veerasamy, TZ Xin, S Gunasagaran, TFW Xiang, EFC Yang, ...
Journal of saudi chemical society 15 (2), 113-120, 2011
7942011
Validation of QSAR models-strategies and importance
R Veerasamy, H Rajak, A Jain, S Sivadasan, CP Varghese, RK Agrawal
Int. J. Drug Des. Discov 3, 511-519, 2011
6282011
Recent Developments and< i> Biological Activities</i> of Thiazolidinone Derivatives: A Review
AK Jain, A Vaidya, V Ravichandran, SK Kashaw
Bioorganic & medicinal chemistry, 2012
5132012
1, 3, 4‐Thiadiazole and its derivatives: A review on recent progress in biological activities
AK Jain, S Sharma, A Vaidya, V Ravichandran, RK Agrawal
Chemical biology & drug design 81 (5), 557-576, 2013
3952013
Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4 (3) H-ones
KS Kumar, S Ganguly, R Veerasamy, E De Clercq
European journal of medicinal chemistry 45 (11), 5474-5479, 2010
3112010
Green synthesis of silver nanoparticles using Atrocarpus altilis leaf extract and the study of their antimicrobial and antioxidant activity
V Ravichandran, S Vasanthi, S Shalini, SAA Shah, R Harish
Materials Letters 180, 264-267, 2016
2722016
Green synthesis, characterization, antibacterial, antioxidant and photocatalytic activity of Parkia speciosa leaves extract mediated silver nanoparticles
V Ravichandran, S Vasanthi, S Shalini, SAA Shah, M Tripathy, N Paliwal
Results in Physics 15, 102565, 2019
2202019
Validation of analytical methods–strategies & importance
V Ravichandran, S Shalini, KM Sundram, R Harish
International Journal of Pharmacy and Pharmaceutical Sciences 2 (3), 18-22, 2010
1862010
2, 5-Disubstituted-1, 3, 4-oxadiazoles/thiadiazole as surface recognition moiety: Design and synthesis of novel hydroxamic acid based histone deacetylase inhibitors
H Rajak, A Agarawal, P Parmar, BS Thakur, R Veerasamy, PC Sharma, ...
Bioorganic & medicinal chemistry letters 21 (19), 5735-5738, 2011
1672011
Predicting anti-HIV activity of 1, 3, 4-thiazolidinone derivatives: 3D-QSAR approach
V Ravichandran, BRP Kumar, S Sankar, RK Agrawal
European journal of medicinal chemistry 44 (3), 1180-1187, 2009
1192009
Design and evaluation of nifedipine transdermal patches
V Sankar, DB Johnson, V Sivanand, V Ravichandran, S Raghuraman, ...
Indian journal of pharmaceutical sciences 65 (5), 510-515, 2003
1132003
Drug utilization studies–an overview
S Shalini, V Ravichandran, R Saraswathi, BK Mohanty, SK Dhanaraj
International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN …, 2010
1112010
Synthesis and antibacterial evaluation of 2–substituted–4, 5–diphenyl–N–alkyl imidazole derivatives
AK Jain, V Ravichandran, M Sisodiya, RK Agrawal
Asian Pacific Journal of Tropical Medicine 3 (6), 471-474, 2010
912010
Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers
H Rajak, P Kumar Dewangan, V Patel, D Kumar Jain, A Singh, ...
Current pharmaceutical design 19 (10), 1923-1955, 2013
812013
Synthesis and antimicrobial activity of Mannich bases of isatin and its derivatives with 2-[(2, 6-dichlorophenyl) amino] phenylacetic acid
V Ravichandran, S Mohan, KS Kumar
Arkivoc 14, 51-57, 2007
812007
Novel semicarbazones based 2, 5-disubstituted-1, 3, 4-oxadiazoles: One more step towards establishing four binding site pharmacophoric model hypothesis for anticonvulsant activity
H Rajak, R Deshmukh, R Veerasamy, AK Sharma, P Mishra, MD Kharya
Bioorganic & medicinal chemistry letters 20 (14), 4168-4172, 2010
772010
Structure–activity relationship analysis of benzimidazoles as emerging anti-inflammatory agents: An overview
R Veerasamy, A Roy, R Karunakaran, H Rajak
Pharmaceuticals 14 (7), 663, 2021
752021
QSAR study of substituted 1, 3, 4-oxadiazole naphthyridines as HIV-1 integrase inhibitors
V Ravichandran, S Shalini, K Sundram, AD Sokkalingam
European Journal of Medicinal Chemistry 45 (7), 2791-2797, 2010
732010
Predicting anti-HIV activity of PETT derivatives: CoMFA approach
V Ravichandran, RK Agrawal
Bioorganic & medicinal chemistry letters 17 (8), 2197-2202, 2007
722007
Novel limonene and citral based 2, 5-disubstituted-1, 3, 4-oxadiazoles: A natural product coupled approach to semicarbazones for antiepileptic activity
H Rajak, BS Thakur, A Singh, K Raghuvanshi, AK Sah, R Veerasamy, ...
Bioorganic & Medicinal Chemistry Letters, 2012
692012
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20